Author Topic: Why not do an in-hospital study comparing Remdesivir with HCQ+ZINC+AZ?  (Read 540 times)

admin

  • Administrator
  • Hero Member
  • *****
  • Posts: 3081
[Update 2-28-21 - or better yet try it side by side against Ivermectin https://www.covidtreatmentoptions.com/#ivermectin - end update]

While I understand that HCQ+ZINC+AZ is 99% effective even in elderly and other high-risk patients, when administered early - that is, as soon as possible after the presentation of symptoms, or even suspicion of COVID - I would be interested to see how the Zelenko Protocol would fare at different stages of hospitalization in comparison to Remdesivir. The Henry Ford and Mt. Sinai studies were done mostly within 24 and most of the rest within 48 hours after admission, from which they recognized a 50% reduction in mortality with the use of HCQ+AZ. It doesn't appear as though either of those studies included all-important zinc in the treatment, and since zinc is the actual virus killer, they likely would have done much better if they had.
https://www.covid-19forum.org/index.php?topic=120.0

In the NIH study of Remdesivir, they concluded there was not a statistically significant reduction in patient mortality. https://www.covid-19forum.org/index.php?topic=19.0
So it isn't hard to imagine how Remdesivir would have compared side by side with HCQ+AZ in the two above named studies. And what if zinc had been added to the Henry Ford and Mt. Sinai studies?

Since the $20 HCQ+Zinc+AZ protocol is so effective in early outpatient treatment and surprisingly effective even without the zinc in newly hospitalized patients, while the performance of $3200 Remdesivir is so comparatively abysmal in terms of patient survival (though it is credited with reducing the length of hospital stay of survivors), I don't imagine it would be difficult to find patients to enter either side of the trial. Even allowing them to choose between the two options after presenting honest and straightforward facts and statistics.

Since survival for the one is so abysmal, and the other what I'm guessing is essentially unknown in the hospital setting with the proper protocol and dosages, I can't imagine how such a study wouldn't also be completely ethical.

It would be great if some doctors or hospital personnel would log in and relate their experiences, and particularly correct me if they have seen the full Zelenko Protocol used in a hospital setting and to what effect.
https://www.covid-19forum.org/index.php?topic=10.0

It wouldn't surprise me if Remdesivir is the most effective drug currently available for the late stages of COVID (though limited reduction of mortality may be an issue), but the whole idea is to treat folks when they first get sick, and keep as many as 97% of them from ever having to see the inside of a hospital. That would also free up hospital space for patients with other ailments, and procedures, that are still being neglected.
« Last Edit: February 28, 2021, 11:32:00 AM by admin »
Over a million Americans have died completely unnecessary, horrific, deaths from COVID-19. Do you have a plan in place to help your family dodge the average $73,300 COVID hospital bill, through prevention and a $20 EARLY treatment protocol? https://www.covidtreatmentoptions.com/